364 related articles for article (PubMed ID: 28268101)
1. Downstaging of bilobar hepatocellular carcinoma after radioembolization with
Reguera-Berenguer L; Orcajo-Rincón J; Rotger-Regí A; Matilla-Peña AM; Echenagusia-Boyra M; Pérez-Pascual R; Marí-Hualde A; Alonso-Farto JC
Rev Esp Med Nucl Imagen Mol; 2017; 36(5):329-332. PubMed ID: 28268101
[TBL] [Abstract][Full Text] [Related]
2. Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma.
Iñarrairaegui M; Pardo F; Bilbao JI; Rotellar F; Benito A; D'Avola D; Herrero JI; Rodriguez M; Martí P; Zozaya G; Dominguez I; Quiroga J; Sangro B
Eur J Surg Oncol; 2012 Jul; 38(7):594-601. PubMed ID: 22440743
[TBL] [Abstract][Full Text] [Related]
3. Use of yttrium-90 microsphere radioembolization of hepatocellular carcinoma as downstaging and bridge before liver transplantation: a case report.
Khalaf H; Alsuhaibani H; Al-Sugair A; Al-Mana H; Al-Mutawa A; Al-Kadhi Y; Al-Sebayel M
Transplant Proc; 2010 Apr; 42(3):994-8. PubMed ID: 20430224
[TBL] [Abstract][Full Text] [Related]
4. Yttrium-90 radioembolization as a bridge to liver transplantation: a single-institution experience.
Tohme S; Sukato D; Chen HW; Amesur N; Zajko AB; Humar A; Geller DA; Marsh JW; Tsung A
J Vasc Interv Radiol; 2013 Nov; 24(11):1632-8. PubMed ID: 24160821
[TBL] [Abstract][Full Text] [Related]
5. Radioembolization using yttrium-90 microspheres as bridging and downstaging treatment for unresectable hepatocellular carcinoma before liver transplantation: initial single-center experience.
Abdelfattah MR; Al-Sebayel M; Broering D; Alsuhaibani H
Transplant Proc; 2015 Mar; 47(2):408-11. PubMed ID: 25769582
[TBL] [Abstract][Full Text] [Related]
6. Favorable survival time provided with radioembolization in hepatocellular carcinoma patients with and without portal vein thrombosis.
Ozkan ZG; Poyanli A; Ucar A; Kuyumcu S; Akyuz F; Keskin S; Saglam S; Yilmaz E; Karaca C; Turkmen C
Cancer Biother Radiopharm; 2015 Apr; 30(3):132-8. PubMed ID: 25760644
[TBL] [Abstract][Full Text] [Related]
7. Downstaging Hepatocellular Carcinoma with Yttrium-90 radioembolization: resection or transplantation?
Ettorre GM; Laurenzi A; Vennarecci G
Eur J Surg Oncol; 2014 Jun; 40(6):789-90. PubMed ID: 24572481
[TBL] [Abstract][Full Text] [Related]
8. Survival benefit of radioembolization for inoperable hepatocellular carcinoma using yttrium-90 microspheres.
Kwok PC; Leung KC; Cheung MT; Lam TW; Szeto LT; Chou SQ; Chia NH; Tong CM; Yuen PK; Cheung CH; Law CK
J Gastroenterol Hepatol; 2014 Nov; 29(11):1897-904. PubMed ID: 24734957
[TBL] [Abstract][Full Text] [Related]
9. Resin Versus Glass Microspheres for
Van Der Gucht A; Jreige M; Denys A; Blanc-Durand P; Boubaker A; Pomoni A; Mitsakis P; Silva-Monteiro M; Gnesin S; Lalonde MN; Duran R; Prior JO; Schaefer N
J Nucl Med; 2017 Aug; 58(8):1334-1340. PubMed ID: 28082436
[TBL] [Abstract][Full Text] [Related]
10. Update on Embolization Therapies for Hepatocellular Carcinoma.
Kishore S; Friedman T; Madoff DC
Curr Oncol Rep; 2017 Jun; 19(6):40. PubMed ID: 28421483
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma.
Golfieri R; Bilbao JI; Carpanese L; Cianni R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Cappelli A; Rodriguez M; Ettorre GM; Saltarelli A; Geatti O; Ahmadzadehfar H; Haug AR; Izzo F; Giampalma E; Sangro B; Pizzi G; Notarianni E; Vit A; Wilhelm K; Jakobs TF; Lastoria S;
J Hepatol; 2013 Oct; 59(4):753-61. PubMed ID: 23707371
[TBL] [Abstract][Full Text] [Related]
12. The Role of Radioembolization in Bridging and Downstaging Hepatocellular Carcinoma to Curative Therapy.
Titano J; Voutsinas N; Kim E
Semin Nucl Med; 2019 May; 49(3):189-196. PubMed ID: 30954184
[TBL] [Abstract][Full Text] [Related]
13. Successful embolization of hepatocelluar carcinoma with yttrium-90 glass microspheres prior to liver transplantation.
Kim DY; Kwon DS; Salem R; Ma CK; Abouljoud MS
J Gastrointest Surg; 2006 Mar; 10(3):413-6. PubMed ID: 16504888
[TBL] [Abstract][Full Text] [Related]
14. Short-term follow-up of radioembolization with yttrium-90 microspheres before liver transplantation: new perspectives in advanced hepatocellular carcinoma.
Ettorre GM; Santoro R; Puoti C; Sciuto R; Carpanese L; Antonini M; Antonucci G; Maini CL; Miglioresi L; Vennarecci G
Transplantation; 2010 Oct; 90(8):930-1. PubMed ID: 20962610
[No Abstract] [Full Text] [Related]
15. Radioembolization for Hepatocellular Carcinoma in Downstaging and Bridging for Liver Transplantation.
Kutlu R; Karatoprak S
J Gastrointest Cancer; 2020 Dec; 51(4):1157-1164. PubMed ID: 32880041
[TBL] [Abstract][Full Text] [Related]
16. Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation.
Sangro B; Carpanese L; Cianni R; Golfieri R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Van Buskirk M; Bilbao JI; Ettorre GM; Salvatori R; Giampalma E; Geatti O; Wilhelm K; Hoffmann RT; Izzo F; Iñarrairaegui M; Maini CL; Urigo C; Cappelli A; Vit A; Ahmadzadehfar H; Jakobs TF; Lastoria S;
Hepatology; 2011 Sep; 54(3):868-78. PubMed ID: 21618574
[TBL] [Abstract][Full Text] [Related]
17. Downstaging to liver resection by radioembolization: a difficult to reach strategy?
Tabone M; Calvo A; Viganò L; Ferrero A
Eur J Surg Oncol; 2013 Aug; 39(8):918-9. PubMed ID: 23743264
[No Abstract] [Full Text] [Related]
18. Downstaging to liver resection by radioembolization: a difficult to reach strategy? Author reply.
Iñarrairaegui M; Pardo F; Sangro B
Eur J Surg Oncol; 2013 Aug; 39(8):920-1. PubMed ID: 23707136
[No Abstract] [Full Text] [Related]
19. Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres.
Wang EA; Stein JP; Bellavia RJ; Broadwell SR
Int J Clin Pract; 2017 Nov; 71(11):. PubMed ID: 28758319
[TBL] [Abstract][Full Text] [Related]
20. (90)Y-glass microspheres for hepatic neoplasia.
Mahnken AH
Future Oncol; 2015; 11(9):1343-54. PubMed ID: 25952780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
